Edition:
United Kingdom

Jounce Therapeutics Inc (JNCE.OQ)

JNCE.OQ on NASDAQ Stock Exchange Global Select Market

3.83USD
5:48pm GMT
Change (% chg)

$-0.12 (-3.04%)
Prev Close
$3.95
Open
$3.97
Day's High
$4.08
Day's Low
$3.78
Volume
19,709
Avg. Vol
78,517
52-wk High
$29.02
52-wk Low
$3.31

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.34 December 10 Dec 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 2 2 2 2
(3) HOLD 2 3 3 3
(4) UNDERPERFORM 1 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.50 2.33 2.33 2.33

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 6 12.63 15.00 9.90 62.83
Quarter Ending Mar-19 4 21.99 44.10 13.38 --
Year Ending Dec-18 6 57.70 60.00 55.00 117.64
Year Ending Dec-19 6 62.09 86.00 43.00 72.42
Earnings (per share)
Quarter Ending Dec-18 6 -0.34 -0.25 -0.46 2.50
Quarter Ending Mar-19 4 -0.07 0.63 -0.33 --
Year Ending Dec-18 6 -1.13 -1.03 -1.24 -0.11
Year Ending Dec-19 6 -1.29 -0.25 -2.33 -2.33

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-18 13.12 14.53 1.40 10.69
Quarter Ending Jun-18 12.91 19.38 6.47 50.13
Quarter Ending Mar-18 15.11 11.19 3.92 25.92
Quarter Ending Dec-17 16.21 12.99 3.22 19.85
Quarter Ending Sep-17 20.00 18.08 1.92 9.62

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 12.63 12.63 12.61 12.61 62.83
Quarter Ending Mar-19 21.99 21.99 23.15 23.15 --
Year Ending Dec-18 57.70 57.70 56.46 56.46 117.64
Year Ending Dec-19 62.09 62.09 68.55 68.55 72.42

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-18 0 0 1 3
Quarter Ending Mar-19 0 0 0 1
Year Ending Dec-18 0 0 2 2
Year Ending Dec-19 0 0 0 2
Earnings